WO2008010231A3 - A process for the purification of topiramate - Google Patents
A process for the purification of topiramate Download PDFInfo
- Publication number
- WO2008010231A3 WO2008010231A3 PCT/IN2007/000211 IN2007000211W WO2008010231A3 WO 2008010231 A3 WO2008010231 A3 WO 2008010231A3 IN 2007000211 W IN2007000211 W IN 2007000211W WO 2008010231 A3 WO2008010231 A3 WO 2008010231A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- topiramate
- purification
- aqueous alkali
- alkali solution
- solution
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epoxy Compounds (AREA)
Abstract
The present invention provides a process for the purification of Topiramate comprising treating Topiramate with aqueous alkali solution followed by washing the aqueous alkali solution of Topiramate with water immiscible solvent and neutralizing this solution to obtain Topiramate having purity at least 99% impurity of formula (II) less than 0.1%.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN810MU2006 | 2006-05-26 | ||
| IN810/MUM/2006 | 2006-05-26 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2008010231A2 WO2008010231A2 (en) | 2008-01-24 |
| WO2008010231A3 true WO2008010231A3 (en) | 2008-05-29 |
Family
ID=38957201
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/IN2007/000211 Ceased WO2008010231A2 (en) | 2006-05-26 | 2007-05-23 | A process for the purification of topiramate |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2008010231A2 (en) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8652527B1 (en) | 2013-03-13 | 2014-02-18 | Upsher-Smith Laboratories, Inc | Extended-release topiramate capsules |
| US9101545B2 (en) | 2013-03-15 | 2015-08-11 | Upsher-Smith Laboratories, Inc. | Extended-release topiramate capsules |
| CN106632530A (en) * | 2016-12-08 | 2017-05-10 | 陕西大生制药科技有限公司 | Preparation method of high-purity topiramate |
| CN110655542A (en) * | 2018-06-29 | 2020-01-07 | 鲁南制药集团股份有限公司 | Crystal form of 2,3:4, 5-bis-O- (1-methylethylidene) -beta-D-fructopyranose chlorosulfonate |
| CN113651861A (en) * | 2020-05-12 | 2021-11-16 | 鲁南制药集团股份有限公司 | Topiramate impurity |
| CN113999228B (en) * | 2021-11-08 | 2022-11-04 | 南京卓康医药科技有限公司 | Synthesis method of tadalafil |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0138441A2 (en) * | 1983-09-26 | 1985-04-24 | McNeilab, Inc. | Anticonvulsant sulfamate derivatives |
| WO2004078769A1 (en) * | 2003-03-04 | 2004-09-16 | Ortho-Mcneil Pharmaceutical Inc. | Process for the preparation of anticonvulsant derivatives of topiramate |
| WO2004108732A1 (en) * | 2003-05-12 | 2004-12-16 | Sun Pharmaceutical Industries Limited | PROCESS FOR THE PREPARATION OF 2,3:4,5-BIS-O(1-METHYLETHYLIDENE)-ß-D-FRUCTOPYRANOSE SULFAMATE |
-
2007
- 2007-05-23 WO PCT/IN2007/000211 patent/WO2008010231A2/en not_active Ceased
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0138441A2 (en) * | 1983-09-26 | 1985-04-24 | McNeilab, Inc. | Anticonvulsant sulfamate derivatives |
| WO2004078769A1 (en) * | 2003-03-04 | 2004-09-16 | Ortho-Mcneil Pharmaceutical Inc. | Process for the preparation of anticonvulsant derivatives of topiramate |
| WO2004108732A1 (en) * | 2003-05-12 | 2004-12-16 | Sun Pharmaceutical Industries Limited | PROCESS FOR THE PREPARATION OF 2,3:4,5-BIS-O(1-METHYLETHYLIDENE)-ß-D-FRUCTOPYRANOSE SULFAMATE |
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008010231A2 (en) | 2008-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008010231A3 (en) | A process for the purification of topiramate | |
| WO2011048148A3 (en) | Glycoside derivative and uses thereof | |
| WO2010078512A4 (en) | Production of substituted phenylene aromatic diesters | |
| MY158326A (en) | Glycoside derivatives and uses thereof | |
| NZ594077A (en) | Process for production of delta-9-tetrahydrocannabinol | |
| WO2007103105A3 (en) | Processes for preparing morphinan-6-one products with low levels of alpha, beta-unsaturated ketone compounds | |
| EP2465823A3 (en) | Washing system for nitroaromatic compounds | |
| WO2009004643A3 (en) | An improved process for preparation of (s)-pregabalin and intermediates thereof | |
| WO2009138847A3 (en) | An improved process for the preparation of cefozopran | |
| EP2374807A3 (en) | An improved process for the isolation of temozolomide | |
| BR0011403A (en) | Processes for the purification and preparation of acrylic acid or methacrylic acid | |
| EP2006274A4 (en) | PROCESS FOR PRODUCING 3,3,3-TRIFLUOROPROPIONIC ACID CHLORIDE | |
| MA29690B1 (en) | PROCESS FOR THE PREPARATION OF 4BETA-AMINO-4'-DEMETHYL-4-DESOXYPODOPHYLLOTOXIN | |
| WO2011073370A3 (en) | Use of 2,3-dihydroxypropyl dodecanoate for treating seborrhea | |
| IL195622A0 (en) | Process for the purification of montelukast | |
| EA200702266A1 (en) | METHOD FOR PREPARING PURE HALOGENIDE SALTS OF ALKALINE AND / OR ALKALINE-LAND METAL AS A RESULT OF HYDROLYTIC TREATMENT OF HALOGENID ORGANIC WASTE | |
| WO2007011951A3 (en) | Purification of paricalcitol | |
| WO2009056483A3 (en) | Process for preparing chlorocyan | |
| WO2007149305A3 (en) | Improved oxidation process with enhanced safety useful in the manufacture of moxidectin by means of stabilised 2-iodoxybenzoic acid (sibx) | |
| BRPI0415019A (en) | mesotrione purification process | |
| WO2007083243A3 (en) | An improved process for the preparation of risedronate sodium hemi-pentahydrate | |
| MX2010007923A (en) | Crystalline form of abacavir that is essentially free of solvent. | |
| WO2006122020A3 (en) | Process for production of 4-biphenylyazetidin-2-ones | |
| WO2007072496A3 (en) | A process to prepare sucralose | |
| CN108373411A (en) | The preparation method of high-purity 4- chloro-3-hydroxyl ethyl butyrates |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 07827503 Country of ref document: EP Kind code of ref document: A2 |